APLS NASDAQ
Apellis Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.4%
3M: +89.1%
YTD: +58.7%
1Y: +145.7%
3Y: -55.1%
5Y: -9.1%
$41.03
Last traded 2026-05-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1B
Revenue
+42.5% YoY
$133M
Net Income
+159.6% YoY
$38M
Free Cash Flow
+549.2% YoY
84.8%
Gross Margin
9.9%
Op. Margin
7.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE46.0%
ROA14.1%
ROIC33.7%
Valuation
P/E38.7
P/B12.5
EV/EBITDA28.5
Leverage
Debt/Equity1.15
Current Ratio3.63
Interest Cov.4.1x
Quality Scores
Piotroski F6/9
Altman Z3.08
Beneish M-1.52